| (210) | Number of the EPO application | 17706945 |
| (220) | Filing date of the EPO application | 2017.02.13 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2023, 2023.06.21 |
| (110) | EPO patent number | 3416684 |
| (11) | Number of the document | MD 3416684 T2 |
| (21) | Number of the application | e 2019 0012 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | GROMADA Jesper, US;
GUSAROVA Viktoria, US;
MURPHY Andrew J., US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (54) | Title of the invention | Methods for treating or preventing atherosclerosis by administering an inhibitor of ANGPTL3 |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); C07K 16/22 (2006.01.01); A61P 3/06 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.10.31 |
| (30) | Priority | 201662296110 P, 2016.02.17, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/US2017/017640, 2017.02.13 |
| (87) | International publication | WO 2017/142832, 2017.08.24 |